Showing results (201-210 of 240) with videos related to

Sort By:
Pageof 24
American Journal of Ophthalmology|April 1, 1995
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeL S Kirsch, J F Arevalo, E De Clercq, et al.
American Journal of Ophthalmology|February 1, 1984
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndromeW R Freeman, C W Lerner, J A Mines, et al.
Ophthalmology|May 16, 2000
Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitisJ C Macdonald, M P Karavellas, F J Torriani, et al.
American Journal of Ophthalmology|January 15, 1992
Visual dysfunction without retinitis in patients with acquired immunodeficiency syndromeJ I Quiceno, E Capparelli, A A Sadun, et al.
Ophthalmology|August 26, 1998
High-dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitisS Young, N Morlet, G Besen, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 6, 1998
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistanceI L Smith, I Taskintuna, F M Rahhal, et al.
Ophthalmology|February 1, 1995
Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral bucklingR F García, M Flores-Aguilar, J I Quiceno, et al.
American Journal of Ophthalmology|July 1, 1996
Correlation between intraocular pressure and CD4+ T-lymphocyte counts in patients with human immunodeficiency virus with and without cytomegalovirus retinitisJ F Arevalo, D Munguia, D Faber, et al.
Ophthalmology|March 1, 1997
Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and preventionE Chavez-de la Paz, J F Arevalo, L S Kirsch, et al.
Current Eye Research|September 12, 2000
The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathyU Ozerdem, B Mach-Hofacre, L Cheng, et al.
Pageof 24